These results support the findings that identified high levels of CD44 mRNA, CD44 protein, and SCL3A2 mRNA expression as prognosticators for local recurrence in HNSCC after adjuvant RCT [36]. The gene discussed is CD44; the disease is head and neck squamous cell carcinoma.